Literature DB >> 7334075

Antigenic scheme of Citrobacter koseri.

I Sechter, G Altmann, D Cahan, I Braunstein, C B Gerichter.   

Abstract

An antigenic scheme, based on the determination of 17 somatic and 9 flagellar antigens, is proposed for Citrobacter koseri. Seven of the flagellar antigens constituted the specific phase (a through g), and the others (1 and 2) were nonspecific. Of the 238 theoretically possible serotypes, 48 were identified among 680 cultures examined.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7334075      PMCID： PMC274009          DOI： 10.1128/jcm.14.6.620-622.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Citrobacter diversus isolated from clinical material.

Authors:  G Altmann; I Sechter; D Cahan; C B Gerichter
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

2.  [Letter: The pathogenic role of Levinae strains isolated from 10 pathogenic products].

Authors:  B Fauconnier; M Cormier; G Fabiani
Journal:  Nouv Presse Med       Date:  1974-09-28

3.  [Meningitis in the newborn caused by levinea malonatica].

Authors:  J G Juif; C Richard; J Lavillaureix; H Berland; P Schneegans; P Beauvalis
Journal:  Arch Fr Pediatr       Date:  1974-10

4.  A new group of enterobacteria, possibly a new Citrobacter sp.

Authors:  E V Booth; S McDonald
Journal:  J Med Microbiol       Date:  1971-08       Impact factor: 2.472

5.  Citrobacter diversus at Grace Hospital, Detroit, Michigan.

Authors:  A Madrazo; J Geiger; C B Lauter
Journal:  Am J Med Sci       Date:  1975 Nov-Dec       Impact factor: 2.378

6.  Gram-negative sepsis in neonates: a nursery outbreak due to hand carriage of Citrobacter diversus.

Authors:  M F Parry; J H Hutchinson; N A Brown; C H Wu; L Estreller
Journal:  Pediatrics       Date:  1980-06       Impact factor: 7.124

7.  Neonatal meningitis caused by Citrobacter koseri.

Authors:  R J Gross; B Rowe; J A Easton
Journal:  J Clin Pathol       Date:  1973-02       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.